文献速递呼吸道感染

心脏生物标志物识别社区获得性肺炎患者早期和长期心血管事件风险

Community-Acquired Pneumonia Patients at Risk for Early and Long-term Cardiovascular Events Are Identified by Cardiac Biomarkers.
PubMed 文献 · Chest · 2019-08-02

研究前瞻性随访730例住院社区获得性肺炎(CAP)患者1年,检测心血管和炎症生物标志物。初始proADM、proendothelin-1、肌钙蛋白、proBNP和IL-6水平在发生心血管事件者中显著更高,生物标志物可独立预测早期和长期心血管事件。

要点

  • 心脏生物标志物可识别CAP患者早期和长期心血管事件高风险。
  • proADM、proendothelin-1、proBNP和肌钙蛋白T独立预测早期事件。
  • proendothelin-1、proADM和proBNP独立预测长期事件。

核心结论

  • 心脏生物标志物有助于识别CAP患者早期和长期心血管事件高风险。
  • 生物标志物可能辅助个性化治疗优化和未来干预研究设计。

研究设计与样本

  • 前瞻性随访730例住院CAP患者1年。
  • 第1天、第4/5天和第30天测量心血管和炎症生物标志物。

主要发现

  • 发生心血管事件者初始proADM、proendothelin-1、肌钙蛋白、proBNP和IL-6水平显著更高。
  • 发生晚期事件者第4/5天下降后至第30天水平保持稳定。

关键数值与推荐

  • 早期事件OR(95%CI):proendothelin-1 2.25(1.34-3.79),proADM 2.53(1.53-4.20),proBNP 2.67(1.59-4.49),肌钙蛋白T 2.70(1.62-4.49)。
  • 长期事件OR(95%CI):proendothelin-1 3.13(1.41-7.80),proADM 2.29(1.01-5.19),proBNP 2.34(1.01-5.56)。
  • 第30天IL-6加入proendothelin-1或proADM后OR分别增至3.53和2.80。

临床怎么用

  • 对住院CAP患者可检测心脏生物标志物以评估早期和长期心血管事件风险。
  • 生物标志物结果可能辅助个性化治疗优化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Community-acquired pneumonia (CAP) increases the risk of cardiovascular complications during and following the episode. The goal of this study was to determine the usefulness of cardiovascular and inflammatory biomarkers for assessing the risk of early (within 30 days) or long-term (1-year follow-up) cardiovascular events. METHODS: A total of 730 hospitalized patients with CAP were prospectively followed up during 1 year. Cardiovascular (proadrenomedullin [proADM], pro-B-type natriuretic peptide (proBNP), proendothelin-1, and troponin T) and inflammatory (interleukin 6 [IL-6], C-reactive protein, and procalcitonin) biomarkers were measured on day 1, at day 4/5, and at day 30. RESULTS: Ninety-two patients developed an early event, and 67 developed a long-term event. Significantly higher initial levels of proADM, proendothelin-1, troponin, proBNP, and IL-6 were recorded in patients who developed cardiovascular events. Despite a decrease at day 4/5, levels remained steady until day 30 in those who developed late events. Biomarkers (days 1 and 30) independently predicted cardiovascular events adjusted for age, previous cardiac disease, Pao2/Fio2 < 250 mm Hg, and sepsis: ORs (95% CIs), proendothelin-1, 2.25 (1.34-3.79); proADM, 2.53 (1.53-4.20); proBNP, 2.67 (1.59-4.49); and troponin T, 2.70 (1.62-4.49) for early events. For late events, the ORs (95% CIs) were: proendothelin-1, 3.13 (1.41-7.80); proADM, 2.29 (1.01-5.19); and proBNP, 2.34 (1.01-5.56). Addition of IL-6 levels at day 30 to proendothelin-1 or proADM increased the ORs to 3.53 and 2.80, respectively. CONCLUSIONS: Cardiac biomarkers are useful for identifying patients with CAP at high risk for early and long-term cardiovascular events. They may aid personalized treatment optimization and for designing future interventional studies to reduce cardiovascular risk.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Menéndez R, Méndez R, Aldás I, et al. Community-Acquired Pneumonia Patients at Risk for Early and Long-term Cardiovascular Events Are Identified by Cardiac Biomarkers. Chest. 2019. PMID: 31381883. doi:10.1016/j.chest.2019.06.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。